Squarepoint
PRPH

Squarepoint’s ProPhase Labs PRPH Stock Holding History

Squarepoint’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,239
Closed -$39.7K – 5231
2024
Q4 		$39.7K Buy
+5,239
New +$73.5K ﹤0.01% 4878
2023
Q3 		– Sell
-1,208
Closed -$87.7K – 4137
2023
Q2 		$87.7K Buy
+1,208
New +$98.3K ﹤0.01% 3383

Other funds holding PRPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

Squarepoint's PRPH Position: Q1 2025 in Review

Squarepoint sold out of ProPhase Labs (PRPH) in Q1 2025, closing a stake of 5,239 shares — an estimated $39.7K sold.

Squarepoint first reported a position in PRPH in Q2 2023 and held it in 2 quarters. The position peaked at $87.7K in Q2 2023. 37 funds tracked by Wall St. Rank hold PRPH as of Q1 2025.

  • Squarepoint reported no remaining ProPhase Labs position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 5,239 ProPhase Labs shares in Q1 2025, an estimated $39.7K.
  • Squarepoint first reported a position in ProPhase Labs in Q2 2023 and held it in 2 quarters.
  • Squarepoint's ProPhase Labs position peaked at $87.7K in Q2 2023.
  • 37 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.